February 2018—Ortho Clinical Diagnostics and EKF Diagnostics announced an agreement that allows Ortho customers to access EKF’s Beta-Hydroxybutyrate LiquiColor Assay, a CLIA moderate-complexity test for use on Ortho’s Vitros 4600 Chemistry System and Vitros 5600 Integrated System. The assay is a marker used in conjunction with clinical findings and other lab tests for the diagnosis and management of ketoacidosis and diabetic ketoacidosis and is used primarily for determining the presence and degree of ketosis in suspected diabetic ketoacidosis cases. The BHB assay produces a quantitative value that is specific to the BHB ketone body.
Ortho and EKF are collaborating to provide the BHB assay as a validated MicroTip Partnership Assay application in the U.S. and Canada. This MPA utilizes the user defined assay feature, which provides the capability to program assay parameters as defined in the EKF-Stanbio assay application sheet.
Ortho Clinical Diagnostics, 800-828-6316
EKF Diagnostics, 830-249-0772